Immunopharmacologic therapy in myasthenia gravis.
Immunotherapy is frequently employed in treatment of patients with myasthenia gravis. Different regimens are not based entirely on controlled or comparative studies. There are few clear guidelines for choosing a particular immunomodulating agent and timing of its introduction. In this article, we have tried to summarize known information about the immunopharmacologic agents used for the treatment of patients with myasthenia gravis.
Shah
A
A
Department of Neurology, Wayne State University School of Medicine, Detroit, Michigan 48201.
Lisak
R P
RP
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D006801:Humans; D007167:Immunotherapy; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000628:therapy*
D000276:Adjuvants, Immunologic